Upon learning of his prostate cancer diagnosis, Tom Regan was reminded of his father's battle with the disease two decades earlier, instilling a sense of apprehension about his own future. Seeking guidance from loved ones, he entrusted his care to Dr. Peter Schulam, Chairman and Professor of Urology at Smilow Cancer Hospital, reigniting hope and shifting his perspective.
Tom's reluctance to undergo routine PSA testing stemmed from recent controversies surrounding its efficacy. However, when a subsequent blood test revealed elevated PSA levels years later, he regretted declining the initial screening. Further tests and a biopsy at Smilow Cancer Hospital confirmed high-grade prostate cancer, prompting a flurry of appointments and consultations, including a second opinion at Dana-Farber Cancer Institute.
While seeking a second opinion was crucial for Tom's peace of mind, it was his initial consultation with Dr. Schulam that solidified his decision to undergo surgery at Smilow. Dr. Schulam's expertise and compassionate approach reassured Tom and his family, alleviating anxiety during a stressful time.
Post-surgery, Tom's physical recovery was swift, but the mental toll proved challenging. Despite initial concerns about potential side effects, including incontinence and sexual dysfunction, Tom found solace in Dr. Schulam's guidance and the supportive environment at Smilow.
Today, Tom celebrates a life free from cancer, attributing his positive outcome to Dr. Schulam's surgical skill and the dedicated team at Smilow. He emphasizes the importance of patients advocating for their care, encouraging others to prioritize routine screenings and seek trustworthy medical guidance.
While Tom acknowledges the ongoing challenges of living with a cancer diagnosis, he remains grateful for each day of health and vitality. His journey serves as a testament to the power of perseverance, the significance of trusted healthcare providers, and the enduring hope for a brighter tomorrow.
